Nentwich Martin M, Rajab Mohammed, Ta Christopher N, He Lisa, Grueterich Martin, Haritoglou Christos, Gandorfer Arnd, Kampik Anselm, Mino De Kaspar Herminia
Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany.
Eur J Ophthalmol. 2012 Jul-Aug;22(4):541-6. doi: 10.5301/ejo.5000093.
To determine the efficacy of 10% povidone iodine (PVI) drops given before cataract extraction in addition to routine irrigation of the conjunctival sac with 1% PVI.
This prospective, randomized, single-center study at the Department of Ophthalmology, Ludwig-Maximilians-University, Munich, includes 263 eyes of 242 patients undergoing cataract surgery. Patients were randomized to receive 3 drops of 10% PVI into the conjunctival sac (study group) or no PVI drops (control group). All patients underwent periorbital disinfection with 10% PVI followed by irrigation of the conjunctiva with 10 mL of 1% PVI. Specimens were obtained prior to the application of PVI, after antibiotic administration (T1), after irrigation with PVI but before surgery (T2), and at the conclusion of surgery (T3).
After PVI disinfection, the number of positive cultures was significantly reduced in all groups (p<0.0001) from 69%-93% at T1 to 1%-16% at T3. In outpatients, the study group showed significantly fewer positive cultures at the conclusion of surgery compared to the control group (4% vs 16%; p=0.03). Also in inpatients significant fewer positive cultures were found in the study group compared to the control group at T2 (12% vs 28%; p=0.03) and at T3 (1% vs 10%; p=0.03).
Three additional drops of 10% PVI prior to surgery provided additional benefit by reducing the conjunctival bacterial contamination rate even in the setting of preoperative irrigation of the conjunctiva with 1% PVI.
确定在白内障摘除术前除了用1%聚维酮碘常规冲洗结膜囊外,给予10%聚维酮碘(PVI)滴眼液的疗效。
这项在慕尼黑路德维希 - 马克西米利安大学眼科进行的前瞻性、随机、单中心研究纳入了242例接受白内障手术患者的263只眼。患者被随机分为在结膜囊内滴入3滴10% PVI的研究组或不滴入PVI滴眼液的对照组。所有患者先用10% PVI进行眶周消毒,然后用10 mL 1% PVI冲洗结膜。在应用PVI之前、给予抗生素后(T1)、用PVI冲洗后但手术前(T2)以及手术结束时(T3)采集标本。
PVI消毒后,所有组的阳性培养物数量均显著减少(p<0.0001),从T1时的69% - 93%降至T3时的1% - 16%。在门诊患者中,与对照组相比,研究组在手术结束时的阳性培养物显著更少(4%对16%;p = 0.03)。在住院患者中,与对照组相比,研究组在T2时(12%对28%;p = 0.03)和T3时(1%对10%;p = 0.03)的阳性培养物也显著更少。
即使在术前用1% PVI冲洗结膜的情况下,手术前额外滴入3滴10% PVI通过降低结膜细菌污染率提供了额外的益处。